Arrowstreet Capital, Limited Partnership Rockwell Medical, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Rockwell Medical, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 55,959 shares of RMTI stock, worth $60,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,959
Previous 106,135
47.28%
Holding current value
$60,995
Previous $216,000
70.83%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RMTI
# of Institutions
53Shares Held
7.13MCall Options Held
92.8KPut Options Held
14.9K-
Armistice Capital, LLC New York, NY2.37MShares$2.58 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.21MShares$1.31 Million0.0% of portfolio
-
Globeflex Capital L P San Diego, CA743KShares$810,1490.08% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny453KShares$493,7710.0% of portfolio
-
Marshall Wace, LLP London, X0334KShares$363,6180.0% of portfolio
About ROCKWELL MEDICAL, INC.
- Ticker RMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 10,675,200
- Market Cap $11.6M
- Description
- Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...